Discover last week's top S&P 500 healthcare gainers, major market stories, and groundbreaking pharma deals, including weight-loss drug updates.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham ...

German science and technology company Merck on Thursday forecast its net sales to be in the range of €21.5 billion ($23.2 ...

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...

Welcome back to our Sunday edition, where we round up some of our top stories and take you inside our newsroom. Jade Bonacolta landed five promotions at LinkedIn in less than seven years. The ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Federal judge finds United HealthCare has antitrust standing Merck, Glenmark’s alleged deal delayed generic Zetia drug Merck & Co. and Glenmark Pharmaceuticals Ltd. failed to convince a federal judge ...

Saks has decided to close Neiman Marcus’ Dallas headquarters office in a cost-saving move, the Dallas Morning News reported. It wasn’t unexpected after privately-owned HBC closed the $2.7 ...

Novartis has announced the beginnings of a major cardiovascular outcomes trial in the UK, as it opened a new headquarters in London. The big Swiss pharma had already made the commitment to conduct ...